How should treatment approaches differ depending on the severity of asthma?

被引:1
|
作者
Kupczyk, Maciej [1 ]
Kuna, Piotr [1 ]
机构
[1] Med Univ Lodz, Dept Internal Med Asthma & Allergy, Lodz, Poland
关键词
Asthma management; endotypes; phenotypes; asthma treatment; asthma guidelines; EOSINOPHILIC AIRWAY INFLAMMATION; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; CHILDHOOD ASTHMA; CLUSTER-ANALYSIS; RESEARCH-PROGRAM; SERUM PERIOSTIN; ALLERGIC-ASTHMA; EUROPEAN-UNION; PHENOTYPES;
D O I
10.1080/17476348.2017.1388742
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Asthma is nowadays regarded as a syndrome of various overlapping phenotypes with defined clinical characteristics, different underlying inflammatory mechanisms, identifiable genetic background, environmental risk factors and possible biomarkers. There are no doubts that due to the diversity of asthma, a one size fits all' management of the disease is no longer valid.Areas covered: Nowadays asthma management is based on the control of the disease, and the goals of asthma treatment are defined as good symptom control, decreased future risk of exacerbations, fixed airflow limitation, and side-effects of treatment. Alternative strategies for adjusting asthma treatment such as sputum or exhaled nitric oxide guided protocols have been evaluated and despite some effectiveness, are regarded as impractical in every-day clinical conditions. Further studies in the field of asthma phenotypes/endotypes and biomarkers are warranted with the main goal to define which of those possible subgroups will be useful in clinical practice in regards to the potential allocation of successful treatment.Expert commentary: Despite the availability of guidelines on the diagnosis and management of asthma, it seems that the disease is still not optimally controlled. Addressing unmet needs in every day care, improving education, adherence/compliance and inhalation technique may significantly improve asthma control across all severities of the disease.
引用
收藏
页码:991 / 1001
页数:11
相关论文
共 50 条
  • [41] How long should Atrovent be given in acute asthma?
    Brophy, C
    Ahmed, B
    Bayston, S
    Arnold, A
    McGivern, D
    Greenstone, M
    THORAX, 1998, 53 (05) : 363 - 367
  • [42] How should we quantify asthma control? A proposal
    Boulet, LP
    Boulet, V
    Milot, J
    CHEST, 2002, 122 (06) : 2217 - 2223
  • [43] Revisiting asthma control: How should it best be defined?
    Hananla, Nicola A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (05) : 483 - 492
  • [44] How Should We Treat Patients with Mild Asthma?
    Wong, Gary W. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2064 - 2066
  • [45] How do treatment in children and adolescent differ?
    Guidetti, V
    Galli, F
    CEPHALALGIA, 2005, 25 (08) : 651 - 651
  • [46] How to diagnose asthma and determine the degree of severity of the disease
    Aït-Khaled, N
    Enarson, DA
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (03) : 252 - 255
  • [47] Defining acute asthma severity - how do worldwide asthma guidelines compare?
    Mcmurray, Ann
    Fleming, Louise
    Cunningham, Steve
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [48] New approaches in childhood asthma treatment
    Castagnoli, Riccardo
    Brambilla, Ilaria
    Giovannini, Mattia
    Marseglia, Gian Luigi
    Licari, Amelia
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 23 (04) : 319 - 326
  • [49] NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF ASTHMA
    GODARD, P
    CHANEZ, P
    REDIER, H
    BOUSQUET, J
    MICHEL, FB
    CELLS AND CYTOKINES IN LUNG INFLAMMATION, 1994, 725 : 367 - 377
  • [50] STATE OF BONE METABOLISM IN PATIENTS WITH CHRONIC PERIODONTITIS, DEPENDING ON THE FORM AND SEVERITY OF BRONCHIAL ASTHMA
    Poleshchuk, O. Y.
    Galkina, O. P.
    Kaliberdenko, V. B.
    Kaladze, K. N.
    Dovbnya, J. A.
    Kuliyeva, E. R.
    Kaladze, K. K.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S579 - S580